These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
529 related articles for article (PubMed ID: 26053182)
1. Targeting the Hedgehog signaling pathway in cancer: beyond Smoothened. Gonnissen A; Isebaert S; Haustermans K Oncotarget; 2015 Jun; 6(16):13899-913. PubMed ID: 26053182 [TBL] [Abstract][Full Text] [Related]
2. Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo. Wickström M; Dyberg C; Shimokawa T; Milosevic J; Baryawno N; Fuskevåg OM; Larsson R; Kogner P; Zaphiropoulos PG; Johnsen JI Int J Cancer; 2013 Apr; 132(7):1516-24. PubMed ID: 22949014 [TBL] [Abstract][Full Text] [Related]
3. Hedgehog-GLI signaling inhibition suppresses tumor growth in squamous lung cancer. Huang L; Walter V; Hayes DN; Onaitis M Clin Cancer Res; 2014 Mar; 20(6):1566-75. PubMed ID: 24423612 [TBL] [Abstract][Full Text] [Related]
4. Targeting GLI Transcription Factors in Cancer. Didiasova M; Schaefer L; Wygrecka M Molecules; 2018 Apr; 23(5):. PubMed ID: 29695137 [TBL] [Abstract][Full Text] [Related]
5. Targeting hedgehog signaling pathway in pediatric tumors: in vitro evaluation of SMO and GLI inhibitors. Arnhold V; Boos J; Lanvers-Kaminsky C Cancer Chemother Pharmacol; 2016 Mar; 77(3):495-505. PubMed ID: 26781311 [TBL] [Abstract][Full Text] [Related]
6. Nonclassical hedgehog-GLI signaling and its clinical implications. Shevde LA; Samant RS Int J Cancer; 2014 Jul; 135(1):1-6. PubMed ID: 23929208 [TBL] [Abstract][Full Text] [Related]
7. Non-canonical Hedgehog Signaling Pathway in Cancer: Activation of GLI Transcription Factors Beyond Smoothened. Pietrobono S; Gagliardi S; Stecca B Front Genet; 2019; 10():556. PubMed ID: 31244888 [TBL] [Abstract][Full Text] [Related]
8. The intrahepatic signalling niche of hedgehog is defined by primary cilia positive cells during chronic liver injury. Grzelak CA; Martelotto LG; Sigglekow ND; Patkunanathan B; Ajami K; Calabro SR; Dwyer BJ; Tirnitz-Parker JE; Watkins DN; Warner FJ; Shackel NA; McCaughan GW J Hepatol; 2014 Jan; 60(1):143-51. PubMed ID: 23978713 [TBL] [Abstract][Full Text] [Related]
9. Targeting GLI factors to inhibit the Hedgehog pathway. Infante P; Alfonsi R; Botta B; Mori M; Di Marcotullio L Trends Pharmacol Sci; 2015 Aug; 36(8):547-58. PubMed ID: 26072120 [TBL] [Abstract][Full Text] [Related]
10. Targeting class I histone deacetylases by the novel small molecule inhibitor 4SC-202 blocks oncogenic hedgehog-GLI signaling and overcomes smoothened inhibitor resistance. Gruber W; Peer E; Elmer DP; Sternberg C; Tesanovic S; Del Burgo P; Coni S; Canettieri G; Neureiter D; Bartz R; Kohlhof H; Vitt D; Aberger F Int J Cancer; 2018 Mar; 142(5):968-975. PubMed ID: 29055107 [TBL] [Abstract][Full Text] [Related]
11. Genomic testing, tumor microenvironment and targeted therapy of Hedgehog-related human cancers. Katoh M Clin Sci (Lond); 2019 Apr; 133(8):953-970. PubMed ID: 31036756 [TBL] [Abstract][Full Text] [Related]
12. Pyrvinium attenuates Hedgehog signaling downstream of smoothened. Li B; Fei DL; Flaveny CA; Dahmane N; Baubet V; Wang Z; Bai F; Pei XH; Rodriguez-Blanco J; Hang B; Orton D; Han L; Wang B; Capobianco AJ; Lee E; Robbins DJ Cancer Res; 2014 Sep; 74(17):4811-21. PubMed ID: 24994715 [TBL] [Abstract][Full Text] [Related]
13. Widespread Expression of Hedgehog Pathway Components in a Large Panel of Human Tumor Cells and Inhibition of Tumor Growth by GANT61: Implications for Cancer Therapy. Réda J; Vachtenheim J; Vlčková K; Horák P; Vachtenheim J; Ondrušová L Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30201866 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of Hedgehog Pathway Inhibitors as a Therapeutic Option for Uterine Leiomyosarcoma Using the Xenograft Model. Garcia N; Ulin M; Ali M; Al-Hendy A; Carvalho KC; Yang Q Reprod Sci; 2022 Mar; 29(3):781-790. PubMed ID: 34642915 [TBL] [Abstract][Full Text] [Related]
15. Mitogen-activated protein kinases and Hedgehog-GLI signaling in cancer: A crosstalk providing therapeutic opportunities? Rovida E; Stecca B Semin Cancer Biol; 2015 Dec; 35():154-67. PubMed ID: 26292171 [TBL] [Abstract][Full Text] [Related]
16. Targeting of Smoothened for therapeutic gain. Ruat M; Hoch L; Faure H; Rognan D Trends Pharmacol Sci; 2014 May; 35(5):237-46. PubMed ID: 24703627 [TBL] [Abstract][Full Text] [Related]
17. GPCR-like signaling mediated by smoothened contributes to acquired chemoresistance through activating Gli. Zhan X; Wang J; Liu Y; Peng Y; Tan W Mol Cancer; 2014 Jan; 13():4. PubMed ID: 24393163 [TBL] [Abstract][Full Text] [Related]
19. Hedgehog signaling mechanism and role in cancer. Jiang J Semin Cancer Biol; 2022 Oct; 85():107-122. PubMed ID: 33836254 [TBL] [Abstract][Full Text] [Related]
20. Digging a hole under Hedgehog: downstream inhibition as an emerging anticancer strategy. Di Magno L; Coni S; Di Marcotullio L; Canettieri G Biochim Biophys Acta; 2015 Aug; 1856(1):62-72. PubMed ID: 26080084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]